Related Articles
Long‑term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor‑resistant gastroesophageal reflux disease
Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors
Use of vonoprazan for management of systemic sclerosis‑related gastroesophageal reflux disease
Efficacy of a potassium‑competitive acid blocker for improving symptoms in patients with reflux esophagitis, non‑erosive reflux disease, and functional dyspepsia
The herbal medicine rikkunshito exhibits strong and differential adsorption properties for bile salts